Total Knee Arthroplasty (uncemented rotating platform ATTUNE)
Total Knee Arthroplasty (uncemented rotating platform ATTUNE): All patients receive an uncemented ATTUNE rotating platform knee system.
Study summary
To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.
Eligibility
Sex
ALL
Min age
21 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria:
* End-stage osteoarthritis of the knee warranting joint replacement therapy.
* Indicated for an ATTUNE total knee system as part of regular clinical practice.
* Capability and willingness to sign informed consent and comply with follow-up procedures.
* Capable enough in Dutch or English to be able to understand study procedures
Exclusion Criteria:
* Unable or unwilling to sign informed consent and comply with follow-up
* Indication for primary revision arthroplasty
* Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)
Primary outcome measure(s)
Survivorship — 10 year Calculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately.
Complication rate — 10 year All substantial complications associated with total knee arthroplasty will be registered and reported
Forgotten Joint Score 12 (FJS-12) — 10 year
Kujala Anterior Knee Pain Scale (AKPS) — 10 year
Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form — 10 year KOOS-PS
Numeric Rating Scale (NRS) — 10 year NRS on pain and satisfaction
EuroQol 5 Dimensions, 3 Levels (EQ5D-3L) — 10 year
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
